Table 3:

Changes in CTGF, HO-1, NT-3 concentrations before and after treatment (x̄±s)

Group	Number of cases	Stage	CTGF (ng/mL)	HO-1 (ng/mL)	NT-3 (pg/Ml)
Control	38	Before treatment	1.95±0.78	2.11±0.34	19.45±2.22
		After treatment	3.45±1.67*	4.05±0.56*	38.12±4.32*
Observation	38	Before treatment	1.91±0.69	2.08±0.31	20.12±2.03
		After treatment	5.03±1.02*#	6.12±0.21*#	59.32±5.01*#

^*Indicates that compared with before treatment ^* P<0.05,

^#Indicates that compared with the control group # P<0.05